| Literature DB >> 27089436 |
Yang Wang1,2, Adriana A Zekveld1,3,4, Graham Naylor5, Barbara Ohlenforst1,2, Elise P Jansma6, Artur Lorens7, Thomas Lunner2,4,8, Sophia E Kramer1.
Abstract
CONTEXT: Although the pupil light reflex has been widely used as a clinical diagnostic tool for autonomic nervous system dysfunction, there is no systematic review available to summarize the evidence that the pupil light reflex is a sensitive method to detect parasympathetic dysfunction. Meanwhile, the relationship between parasympathetic functioning and hearing impairment is relatively unknown.Entities:
Mesh:
Year: 2016 PMID: 27089436 PMCID: PMC4835104 DOI: 10.1371/journal.pone.0153566
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Pupil light reflex pathway.
Red and blue lines represent the afferent pathway, the ganglion cell axons project to the pretectal region of the midbrain; green line represents the efferent pathway, the signal transmits from preganglionic parasympathetic fiber to ciliary ganglion, finally to the constrictor muscles through the short posterior ciliary nerve.
Fig 2demonstration of one pupil light reflex on pupillometry.
The light onsets at the ‘0’ point; Phase 1 is a fast constriction mainly controlled by PNS; Phase 2 is a fast redilation under the control of both PNS and SNS; Phase 3 is a slow redilation phase, predominantly controlled by SNS activity.
Fig 3Structure of the review.
Search steps and results of PubMed.
| Search | PubMed Query 30-10-2014 | Items found |
|---|---|---|
| Search | ||
| Search | ||
| Search | ||
| Search | ||
| Search | ||
| Search | ||
| Search | ||
| Search |
Fig 4PRISMA flow diagram showing process for filtering search results and selecting studies for inclusion.
Summary of the studies comparing PLR parameters between PD patients and normal controls.
| PLR parameters | Studies including this PLR parameter | Result |
|---|---|---|
| MCV | [ | + 0 |
| MCA | [ | + + |
| ACA | [ | + + + |
| RCA | [ | + |
| Latency | [ | + + + |
| Constriction time | [ | 0 + |
| Constriction velocity | [ | 0 |
Note: “+” indicates a result in agreement with the hypothesis of the present paper, “0” means that no statistically significant effect was found.
Giza et al. [3]
Fotiou et al. [4]
Micieli et al. [31]
Kang et al. [32]
Summary of the studies asessesing PLR parameters in Alzheimer’s disease patients and normal controls.
| PLR parameters | Studies including this PLR parameter | Result |
|---|---|---|
| MCV | [ | + |
| MCA | [ | + |
| ACA | [ | + 0 0 |
| RCA | [ | + + 0 |
| Latency | [ | + 0 0 0 |
| Constriction time | [ | + + |
Note: “+” indicates a result in agreement with the hypothesis of the present paper, “0” means no statistically significant effect was found.
Fotiou et al. [4]
Tales et al. [33]
Fotiou et al. [34]
Bittner et al. [35]
Summary of the studies about the relationship between age and PLR parameters.
| PLR parameters | Studies including this PLR parameter | Result |
|---|---|---|
| MCV | [ | + + (only when youngest compared to oldest) |
| MCA | N/A | |
| ACA | [ | + + |
| RCA | [ | + |
| Latency | [ | + 0 |
| Constriction time | [ | 0 |
Note: “+” indicates a result in agreement with the hypothesis of the present paper, “0” means no statistically significant effect was found.
Bitsios et al. [8]
Pozzessere et al. [40]
Summary of studies about the PLR in DM patients and normal controls.
| PLR parameters | Studies including this PLR parameter | Result |
|---|---|---|
| MCV | [ | + (only E-DM vs control) + (only Diabetic Neuropathy (DNP) vs control) + + 0 0 + (DNP vs non-DNP) |
| MCA | N/A | |
| ACA | [ | + (only DNP vs control) + (only E-DM vs control) + + + 0 + (DNP vs non-DNP) |
| RCA | [ | + (only B-DM vs control) 0 0 0 |
| Latency | [ | + (only DNP vs control) 0 + + + + + + |
| Constriction time | [ | 0 0 |
Note: “+” indicates a result in agreement with the hypothesis of the present paper, “0” means no statistically significant effect was found.
Lanting et al. [5]
Kuroda et al. [42]
Zangemeister et al. [43]
Dutsch et al. [44]
Ferrari et al. [45]
Pfeifer et al. [46]
Levy et al. [47]
Yuan et al. [48]
de Vos et al. [49]
Pfeifer et al. [50]
Summary of the studies about the PLR in obese groups and non-obese controls.
| PLR parameters | Studies including this PLR parameter | Result |
|---|---|---|
| MCV | [ | 0 0 |
| MCA | N/A | |
| ACA | [ | 0 0 |
| RCA | [ | 0 |
| Latency | [ | 0 |
| constriction time | [ | 0 |
Note: “+” indicates a result in agreement with the hypothesis of the present paper, “0” means no statistically significant effect was found.
Piha et al. [53]
Baum et al. [54]
Summary of the studies about the influence of schizophrenia on PLR parameters.
| PLR parameters | Studies including this PLR parameter | Result |
|---|---|---|
| MCV | [ | 0 |
| MCA | N/A | |
| ACA | [ | 0 |
| RCA | [ | + |
| Latency | [ | 0 |
| Constriction time | [ | + |
| Flatness of curve | [ | 0 |
Note: “+” indicates a result in agreement with the hypothesis of the present paper, “0” means no statistically significant effect was found.
Bar et al. [6]
Hakerem et al. [58]
Summary of the results of the studies about the relationship between migraine patients and normal controls when comparing with PLR parameters.
| PLR parameters | Studies including this PLR parameter | Result |
|---|---|---|
| MCA | N/A | |
| ACA | [ | 0 + 0 |
| RCA | N/A | |
| Latency | [ | 0 0 + |
| Constriction time | [ | + |
| Constriction velocity (ACA/Constriction time) | [ | + |
Note: “+” indicates a result in agreement with the hypothesis of the present paper, “0” means no statistically significant effect was found.
Mylius et al. [62]
Micieli et al. [63]
Harle et al. [64]
Summary of the studies about the influence of rheumatoid arthritis on the PLR.
| PLR parameters | Studies including this PLR parameter | Result |
|---|---|---|
| MCV | [ | + |
| MCA | N/A | |
| ACA | N/A | |
| RCA | [ | + |
| Latency | [ | + |
| Average Constriction Velocity | [ | + |
| Constriction time | [ | + |
Note: “+” indicates a result in agreement with the hypothesis of the present paper, “0” means no statistically significant effect was found.
Perry et al. [70]
Barendregt et al. [72]
Counts of PLR constriction parameters used in all the 36 PLR+PNS studies.
| Latency | ACA | MCV | RCA | Constriction time | MCA | Time to MCV | |
|---|---|---|---|---|---|---|---|
| Total N | 28 | 24 | 21 | 15 | 12 | 4 | 2 |
| N showing difference | 16 | 18 | 18 | 11 | 6 | 3 | 2 |
| % showing difference | 57 | 75 | 86 | 73 | 50 | 75 | 100 |
Total N, how many studies used the given parameter; N showing difference, how many studies found a significant difference in the given parameter between patient and control groups; % showing difference, = (N showing difference) / (Total N) x 100.